Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step copper-catalyzed route for azabicyclo hexanone. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109232284B reveals a novel acid-catalyzed route for polysubstituted enamine aldehydes, offering high yields and simplified purification for pharmaceutical manufacturing.
Patent CN102887860B reveals high-yield synthesis for pharmaceutical intermediates. Enhanced process stability offers significant supply chain and cost advantages for global buyers.
Novel synthesis route for chiral nitrophenol intermediates reduces cost and improves purity. Reliable supply for pharmaceutical manufacturing scale-up.
Patent CN108794448B reveals a high-yield Pd-catalyzed route for Trelagliptin, offering superior purity and cost efficiency for API manufacturing supply chains.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.
Novel iron-catalyzed synthesis offers high purity and cost efficiency for pharmaceutical intermediates supply chains globally ensuring reliable production and significant cost reduction.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Patent CN114232013B reveals a metal-free electrochemical route for indoloquinolines. Discover cost-effective, green manufacturing solutions for high-purity pharmaceutical intermediates.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Novel amide-mediated route for Bempedoic Acid reduces steps and improves purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN111909113A details a metal-free route to 2-substituted benzothiazoles using elemental sulfur, offering significant cost reduction and simplified supply chain management.
Patent CN118307476A reveals a novel nickel-catalyzed synthesis for tetra-substituted olefins using isoprene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN111548325A details a novel synthesis of 7-chloro-benzothiazepine-1,1-dioxide, offering improved yield and halogen introduction for reliable pharmaceutical intermediate supply chains.
Patent CN104926674B details a novel route for Z-unsaturated amides offering safer processing and reduced waste for global pharmaceutical intermediate supply chains.
Novel green nitration process for high-energy azaadamantane derivatives ensuring high purity and reduced waste for reliable supply chain partners.
Patent CN117843613A reveals high-yield synthesis for dabigatran intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel aqueous synthesis of diazinium derivatives using phosphotungstic acid. Offers high yield, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN102040614A reveals a water-phase method for Cephalothin Acid, reducing solvent use by over 70% and enhancing safety for API manufacturing supply chains.